{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "6651352", "DateCompleted": {"Year": "1984", "Month": "01", "Day": "07"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0003-9896", "JournalIssue": {"Volume": "38", "Issue": "5", "PubDate": {"Year": "1983", "Season": "Sep-Oct"}}, "Title": "Archives of environmental health", "ISOAbbreviation": "Arch Environ Health"}, "ArticleTitle": "Response to ozone in volunteers with chronic obstructive pulmonary disease.", "Pagination": {"StartPage": "278", "EndPage": "283", "MedlinePgn": "278-83"}, "Abstract": {"AbstractText": ["Twenty-eight volunteers with chronic obstructive pulmonary disease were exposed to 0.0, 0.18, and 0.25 ppm ozone in purified air for 1-hr periods with light intermittent exercise, with exposure conditions presented in random order at 1-month intervals. No statistically significant changes attributable to ozone were found in forced expiratory performance or percent oxyhemoglobin (measured near the beginning and end of each exposure). No ozone-related changes in clinical status were found by interviews that included the time for 1 wk before to 1 wk after each exposure, except that a moderate increase in lower respiratory symptoms was reported by nonsmokers in 0.18 ppm exposures only. Thus, a slight decrement in hemoglobin saturation with ozone exposure (reported in two previous studies of chronic obstructive pulmonary disease subjects) may not be a common occurrence under typical ambient exposure conditions."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Linn", "ForeName": "W S", "Initials": "WS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shamoo", "ForeName": "D A", "Initials": "DA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Venet", "ForeName": "T G", "Initials": "TG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Spier", "ForeName": "C E", "Initials": "CE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Valencia", "ForeName": "L M", "Initials": "LM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Anzar", "ForeName": "U T", "Initials": "UT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hackney", "ForeName": "J D", "Initials": "JD"}], "PublicationTypeList": ["Clinical Trial", "Controlled Clinical Trial", "Journal Article", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Arch Environ Health", "NlmUniqueID": "0212627", "ISSNLinking": "0003-9896"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hemoglobins"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Atmosphere Exposure Chambers"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Rate"}, {"QualifierName": ["analysis"], "DescriptorName": "Hemoglobins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Lung Diseases, Obstructive"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Physical Exertion"}, {"QualifierName": ["drug effects"], "DescriptorName": "Pulmonary Ventilation"}, {"QualifierName": [], "DescriptorName": "Smoking"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1983", "Month": "9", "Day": "1"}, {"Year": "1983", "Month": "9", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1983", "Month": "9", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6651352", "10.1080/00039896.1983.10544007"]}}], "PubmedBookArticle": []}